Edward Neugeboren serves as Executive at ELITE PHARMACEUTICALS INC /DE/, where they oversee executive responsibilities. Since joining the company, Edward Neugeboren has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 8, 2026 involved receiving (via award) 10,000 shares valued at $0.
Edward Neugeboren currently holds 10,000 shares of ELITE PHARMACEUTICALS INC /DE/ (ELI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward Neugeboren has been a net neutral trader of ELI stock. They have purchased $0 and sold $0 worth of shares.
Edward Neugeboren's most recent insider trade was on Jan 8, 2026, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.54 |
| Discretionary |